Formulated product
TOPALGIC 100 mg/ml, solution buvable
Formulated product. The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
1 studies reference this formulated product.
1 studies mention this registry entry. Counts describe the source entry and do not establish exposure to an individual molecule.
Success Metrics
Active Trials
1(100%)
Phase Distribution
Ph phase_4
1
100%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
1
all time
Status Distribution
Active(1)
Detailed Status
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
1
Active
1
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 41 (100.0%)
Trials by Status
recruiting1100%
Recent Activity
Clinical Trials (1)
Showing 1 of 1 trials
All 1 trials loaded
Drug Details
- Intervention Type
- Type not reported
- Total Trials
- 1